
| Niacin | 20 mg | 100% |
| Proprietary Thermogenic Blend | 243.34 mg | † |
| Caffeine Anhydrous | ||
| Capsimax(TM) Capsicum Fruit Extract | ||
| Black Pepper extract |
Other ingredients: Cellulose, Gelatin, Titanium Dioxide, Artificial Colors
% Daily Values for: Adults and children 4 or more years of age.
Where this label comes from
An original label of the NIH's Dietary Supplement Label Database, entered there on 25 March 2014, shown here as it was entered. The NIH's record
General information
- Product name
- X-12
- Brand
- GNC Pro Performance AMP
- Barcode (UPC)
- Not printed
- Net contents
- 30 Pak(s)
- Market status
- Off market
- DSLD ID
- 31718
Classification
- Supplement form
- Capsule
- Product type
- Other Combinations
- Claim types on the label
- All Other, Structure/Function
- Intended for
- Adult Female (18 - 50 Years), Gluten Free, Dairy Free
Label statements
Formula: Contains: X-12 contains 200 mg of caffeine along with a proven blend of piperine, Capismax(TM) and niacin to increase energy, enhance metabolism and support improved endurance.*
Formula: Contains: Total caffeine per capsule 200 mg.
FDA Statement of Identity: DIETARY SUPPLEMENT
Directions: DIRECTIONS: As a dietary supplement, for optimal health benefits, take contents of one packet daily with food every morning. On workout days, for individuals looking to maximize energy production, X-12 can be taken 30-60 minutes prior to exercise.
Brand information
Distributed by: General Nutrition Corporation, Pittsburgh, PA
More labels from GNC Pro Performance AMP
Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.
